Vulsteke C, Chambers SK, Perez MJR, Chan JK, et al. Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy. Eur J Cancer 2024;208:114157.
PMID: 39013265